INTERNATIONAL PATENT: MEDIMMUNE, LLC, AMGEN INC. FILES APPLICATION FOR "TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ANTI-TSLP ANTIBODY"

GENEVA, July 14 -- MEDIMMUNE, LLC (One Medlmmune WayGaithersburg, MD 20878), AMGEN INC. (One Amgen Center DriveThousand Oaks, CA 91320-1799) filed a patent application (PCT/US2025/010264) for "TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH ANTI-TSLP ANTIBODY" on Jan 03, 2025. With publication no. WO/2025/147632, the details related to the patent application was published on Jul 10, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): COLICE, Gene (C/o Medlmmune LLCOne Medlmmune WayGaithersburg, MD 20878), PETERFFY, Annamaria, Jasmine (C/o Medlmmune LLCOne Medlmmune WayGaithersburg, MD 20...